Novel oral, multi-kinase inhibitor therapy effective in exudative AMD: APEX trial Dr Ishan Kataria26 Jun 2021 2:30 AM GMTAge-related macular degeneration (AMD) is one of the most common causes of visual loss, projected to affect nearly 200 million people worldwide....
Novel eyedrop is promising wet AMD treatment Hina Zahid7 May 2021 3:30 AM GMTRockville, Md. - New research has resulted in a new potential therapeutic option for vascular endothelial growth factor (VEGF) after being...
Exposure to Air pollution May Lead to Permanent Vision Loss: study MD Bureau28 Feb 2021 5:25 PM GMTAir pollution is a global and major public health problem. The Global Burden of Diseases, Injuries, and Risk factors Study reported that air pollution ...
Low Dose of Metformin May Prevent Development of AMD: JAMA Study MD Bureau30 Jan 2021 5:45 AM GMTMetformin, classified as biguanide, is the first - line and most widely used medication for patients with type 2 diabetes. In addition to its main...
Air pollution linked to heightened risk of progressive and irreversible sight loss Hina Zahid26 Jan 2021 12:30 AM GMTAir pollution is linked to a heightened risk of progressive and irreversible sight loss, known as age related macular degeneration, or AMD for short,...
